Research by Joel Cantor et al. “Access to Hepatitis C Treatment during and after Incarceration in New Jersey, United States: A Qualitative Study”

April 17, 2023

Abstract

Despite effective antiviral therapy for hepatitis C virus (HCV), people who are incarcerated and those returning to the community face challenges in obtaining HCV treatment. We aimed to explore facilitators and barriers to HCV treatment during and after incarceration. From July–November 2020 and June–July 2021, we conducted 27 semi-structured interviews with residents who were formerly incarcerated in jail or prison. The interviews were audio-recorded and professionally transcribed. We used descriptive statistics to characterize the study sample and analyzed qualitative data thematically using an iterative process. Participants included five women and 22 men who self-identified as White (n = 14), Latinx (n = 8), and Black (n = 5). During incarceration, a key facilitator was having sufficient time to complete HCV treatment, and the corresponding barrier was delaying treatment initiation. After incarceration, a key facilitator was connecting with reentry programs (e.g., halfway house or rehabilitation program) that coordinated the treatment logistics and provided support with culturally sensitive staff. Barriers included a lack of insurance coverage and higher-ranking priorities (e.g., managing more immediate reentry challenges such as other comorbidities, employment, housing, and legal issues), low perceived risk of harm related to HCV, and active substance use. Incarceration and reentry pose distinct facilitators and challenges to accessing HCV treatment. These findings signal the need for interventions to improve engagement in HCV care both during and after incarceration to assist in closing the gap of untreated people living with HCV.

Keywords: HCV; Hepatitis C; treatment; direct-acting antiviral DAA; prison; jail; incarceration; linkage to care; qualitative

Citation

Kamat, Samir, Sankeerth Kondapalli, Shumayl Syed, Gabrielle Price, George Danias, Ksenia Gorbenko, Joel Cantor, Pamela Valera, Aakash K. Shah, and Matthew J. Akiyama. 2023. “Access to Hepatitis C Treatment during and after Incarceration in New Jersey, United States: A Qualitative Study” Life 13, no. 4: 1033. https://doi.org/10.3390/life13041033

Recent Posts

Molloy Discusses Criteria for Healthiest Cities

Location matters when it comes to health. Some places promote wellness by expanding access to nutritious food and recreational facilities. Others strive to keep healthcare costs affordable for everyone or keep parks clean and well-maintained. When a city doesn’t take...

McGlynn & Payne Explore the Relational Reprojection Platform

Counter-GIS Experiments in Distance Interpolation with the Relational Reprojection Platform Abstract In this paper, we discuss the cartographic genealogy and prospective uses of the Relational Reprojection Platform (RRP), an interactive tool that we built to create...

Clint Andrews–The Critical Role of University Research

The Critical Role of University Research: Funding, Challenges, and Impact This week on EJB Talks dean Stuart Shapiro and Associate Dean of Research Clint Andrews discuss the vital role federal-funded university research plays in complementing education, driving...

Payne Investigates City Digital Twins Concepts

Expanding the city digital twin in the context of crisis, cartography and computation Abstract This commentary responds to Gillian Rose's ‘Visualising human life in volumetric cities: city digital twins and other disasters’ as a framework for thinking about crisis and...

Nashia Basit (MPP/MCRP ’24) on Women’s Leadership

This week, alumna and current Governor's Fellow Nashia Basit (MPP/MCRP '24) discussed women's leadership in state government and cultivating spaces for women to be successful with Allison Chris Myers, Esq., CEO of the New Jersey Civil Service Commission....